Motivating Behaviour Change in Young Cannabis Users

Not Applicable

• Conditions: Cannabis use; Mental Health - Addiction

• Registration Number: ACTRN12611000177954
• Lead Sponsor: Institute of Health and Biomedical Innovation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-02-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Inclusion criteria are: i) aged 16-25; (ii) cannabis use > weekly in the past month. Users of illicit drugs other than cannabis can participate, as can smokers and problem-drinkers, as long as cannabis is most problematic or most frequently used.

Exclusion Criteria

Exclusion criteria are: (i) unable to speak and read English; (ii) estimated IQ < 80; (iii) history of psychosis, traumatic brain injury, organic brain disease or significant cognitive impairment; or (iv) concurrent psychological treatment for cannabis use or other substance use.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Treatment Engagement and Completion as sessed by number of sessions attended and the Working Alliance Inventory.[1 month follwo-up];Drug Use as measured by the Timeline Followback, the Alcohol, Smoking and Substance Involvement Screening Test, the Severity of Dependence Scale and the Readiness to Change Questionnaire[Assessed at Baseline, 1, 3, 6 and 12 months.];Psychological Distress and General Functioning as assessed by the Kessler 10, the Global Assessment of Functioning, the Social and Occupational Functioning Scale, the Modified Vocational Status Index and the Modified Location Code Index; Coping in stressful situations, as measured by the Coping Inventory for Stressful Situations.[Assessed at Baseline, 1, 3, 6 and 12 months.]

Secondary Outcome Measures

Name	Time	Method
Treatment Fidelity as measured by the Yale Adherence and Competence Scale[1, 3, 6 and 12 months];cost effectiveness as measured by the Short Form-12 (SF12) Health Survey and a total health care and a personal cost perspective.[1, 3, 6 and 12 months]